4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0002047607-26-000004
Chief Strategy Officer acquired 34,200 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Riley Jennifer · Chief Strategy Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-05-21 | Grant or award : show line 1 in the form | +34,200 | 36,855 | D |
Loading xslF345X06/form4-05262026_040508.xml…